The weekly litigation news digest is live. Subscribe now

Combinations Of Akt Inhibitor Compounds And Abiraterone, And Methods Of Use - EP2694072

The patent EP2694072 was granted to Genentech on Aug 7, 2024. The application was originally filed on Mar 30, 2012 under application number EP12764765A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2694072

GENENTECH
Application Number
EP12764765A
Filing Date
Mar 30, 2012
Status
Patent Maintained As Amended
Jul 5, 2024
Publication Date
Aug 7, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKAug 29, 2018ELKINGTON AND FIFEADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5604213
DESCRIPTIONUS5618807
OPPOSITIONUS2008051399
OPPOSITIONUS2009013795
OPPOSITIONUS2010069357
SEARCHUS2008051399

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents